You are here

29-06-2018

2935Organoids in the fight against cancer

Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate genetic events in CRC, as tools to test novel therapeutics.

22-05-2018

2876Sailing the mysteries of old maps

Dr Joaquim Alves Gaspar is a man of the sea. After many years in the Portuguese Navy, he gave up plans to become an admiral in favour of pursuing a PhD in the History of Cartography. This second career led him to receive an ERC Starting Grant, the first awarded in this budding discipline. With his highly multidisciplinary team (he likes to say that, to work with him, one must be a mathematician fluent in Latin), and the experience obtained as a navigator and navigational instructor, Dr Gaspar hopes to understand how and when the first nautical charts were created. The MEDEA-CHART team is the best place in Portugal, and probably in the world, to study the history of nautical cartography, hoping that this work will provide the domain with its rightful recognition within world history.

01-04-2017

2992Frontier science and business that makes a difference

Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.

Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."

30-11-2016

1332Gut bacteria could hold key to new treatments

An ERC-funded project has significantly increased understanding of the crucial role that microorganisms in the gut play in maintaining health. The findings have since led to a patent, as well as a follow-on project that could one day steer the way to new targeted treatments for diseases, including cancer.

12-07-2016

1314Evolution of species: different, but not so different

Through her work with the fruit fly Drosophila santomea, Dr Virginie Orgogozo aims to answer one of the most challenging questions of modern evolutionary biology: how do observable characteristics change between species and yet remain stable in a given species?

29-06-2016

1313Stem cells: from frontier research project to promising spin-off company

Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.

02-05-2016

1129The past and present of slavery: a history in the making

Slavery represents a dark and unclosed page in the history of mankind. Even if legally abolished by all countries of the world, its legacies shape the present in a plurality of ways and often overlap with the phenomena that scholars, activists and policy-makers target as new slaveries. Which are the consequences of slavery after its legal death? Should new forms of labor exploitation and human bondage also be read in this key? Or are they the result of recent economic, political and social transformations?

29-04-2016

1310Discovery in Kenya sheds light on the origins of warfare

A ground-breaking anthropological discovery took place in East Africa, where ERC Advanced grantee Dr Marta Mirazón Lahr and her team have been studying human origins. At the excavation site in Nataruk in northern Kenya, they have stumbled upon a real archaeological rarity – the earliest historical evidence of warfare.

21-03-2016

1308International recognition for ERC-funded research in archaeology

During the 3rd and 2nd millennium BC, the European continent experienced important social and cultural transformations, with the introduction of metal and the emergence of new languages and identities. Recent theories suggest that these major changes were triggered by people’s migrations and cultural transmissions, challenging the perception of European prehistory as a series of unrelated local developments.

10-11-2015

1294An international career to push the frontiers of epigenetics

With her degree in biology, Dr Maria-Elena Torres-Padilla left Mexico and embarked on an international career in epigenetics. She completed her PhD at the Pasteur Institute in Paris and then moved to Cambridge University. In 2006 she joined IGBMC in Strasbourg working as a group leader. She has just been appointed Director of the Institute of Epigenetics and Stem Cells of the Helmholtz Zentrum in Munich. Supported by an ERC grant, she studies the mechanisms controlling embryonic cellular plasticity with the aim of shedding new light on today's fertility issues. In this interview she shares her story as a non-European scientist in Europe.